- Home
- IRON vs DEA Comparison
IRON vs DEA Comparison
Compare IRON & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- DEA
- Stock Information
- Founded
- IRON 2017
- DEA 2011
- Country
- IRON United States
- DEA United States
- Employees
- IRON N/A
- DEA N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- DEA Real Estate Investment Trusts
- Sector
- IRON Health Care
- DEA Real Estate
- Exchange
- IRON Nasdaq
- DEA Nasdaq
- Market Cap
- IRON 1.4B
- DEA 1.2B
- IPO Year
- IRON N/A
- DEA 2015
- Fundamental
- Price
- IRON $64.03
- DEA $11.64
- Analyst Decision
- IRON Strong Buy
- DEA Buy
- Analyst Count
- IRON 10
- DEA 2
- Target Price
- IRON $73.70
- DEA $14.00
- AVG Volume (30 Days)
- IRON 253.9K
- DEA 1.5M
- Earning Date
- IRON 11-12-2024
- DEA 11-05-2024
- Dividend Yield
- IRON N/A
- DEA 9.10%
- EPS Growth
- IRON N/A
- DEA N/A
- EPS
- IRON N/A
- DEA 0.17
- Revenue
- IRON N/A
- DEA $302,121,000.00
- Revenue This Year
- IRON N/A
- DEA N/A
- Revenue Next Year
- IRON N/A
- DEA $7.27
- P/E Ratio
- IRON N/A
- DEA $68.16
- Revenue Growth
- IRON N/A
- DEA 2.98
- 52 Week Low
- IRON $25.60
- DEA $10.94
- 52 Week High
- IRON $77.60
- DEA $14.53
- Technical
- Relative Strength Index (RSI)
- IRON 53.08
- DEA 30.44
- Support Level
- IRON $62.31
- DEA $11.62
- Resistance Level
- IRON $67.87
- DEA $11.95
- Average True Range (ATR)
- IRON 3.04
- DEA 0.22
- MACD
- IRON -0.46
- DEA 0.02
- Stochastic Oscillator
- IRON 38.78
- DEA 13.02
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.